Bull Run

India's AI-powered stock screener for NSE & BSE. 5,000+ stocks with fundamentals and real-time analysis.

info@bullrun.co.in

Navigate

  • Home
  • Smart Screener
  • Stock Battle Arena
  • Watchlist
  • Go Premium

Tools

  • Advanced Stock Screening
  • Stock Comparison Tool
  • Personal Watchlist
  • Ask AI Assistant
  • Browse All Stocks
  • IPO GMP Tracker
  • Market News & Blog

Indices

  • All Indices
  • Nifty 50 Stocks
  • Sensex Stocks
  • Nifty Bank
  • Nifty IT
  • Nifty Pharma
  • Nifty Midcap 100

Screeners

  • Top Dividend Stocks
  • Debt Free Stocks
  • Undervalued Stocks
  • High ROE Stocks
  • Low PE Stocks
  • Top Rated Stocks
  • Large Cap Stocks
  • Compare Stocks
  • Browse by Sector

Browse Stocks by Sector

View All →
Non Banking Financial Company (NBFC)PharmaceuticalsComputers - Software & ConsultingIndustrial ProductsCivil ConstructionAuto Components & EquipmentsSpecialty ChemicalsOther Financial ServicesIT Enabled ServicesPackagingHotels & ResortsCommodity ChemicalsOther Electrical EquipmentGarments & ApparelsPaper & Paper ProductsSoftware ProductsPackaged FoodsCement & Cement ProductsSugarHeavy Electrical EquipmentHospitalEdible OilPower GenerationHealthcare Service Provider
© 2026 Bull Run. All rights reserved.
AboutBlogPrivacy PolicyTerms of Service

Disclaimer: Ratings and scores are generated algorithmically from publicly available market data for educational and informational purposes only. They do not constitute investment advice or solicitation to buy/sell securities. Bull Run is not a SEBI-registered Research Analyst or Investment Adviser.

  1. Home
  2. /
  3. Sectors
  4. /
  5. Hospital
  6. /
  7. Abateas Industries Ltd
Financial RatiosPE RatioShareholdingDividendQuarterly ResultsBalance SheetProfit & LossCash Flow
HomeStocksHospitalAbateas Industries Ltd

Abateas Industries Ltd Stock Price Today (NSE: ABATEAS)

Abateas Industries Ltd

ABATEASHospital
₹11.10₹0.26 (2.21%)↓
As on 30 Mar 2026, 12:04 pm ISTMarket Closed

Fundamental Score

...

Abateas Industries Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Abateas Industries Ltd share price today is ₹11.10, down 2.21% on NSE/BSE as of 30 March 2026. Abateas Industries Ltd (ABATEAS) is a Small-cap company in the Hospital sector with a market capitalisation of ₹263.20 (Cr). The 52-week high for ABATEAS share price is ₹26.20 and the 52-week low is ₹9.62. At a P/E ratio of 50.62x, ABATEAS is currently trading below its industry average P/E of 52.84x.

Abateas Industries Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
₹0.00
Low
₹0.00
Volume
0
Change
-2.21%

Returns & Performance

ROE

N/A

ROCE

N/A

OPM (5Y)

N/A

Div Yield

0.00%

Abateas Industries Ltd Valuation Check

Average

P/E Ratio

50.62x
Poor

Industry P/E

52.84x
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Market Cap

263.20 (Cr)

Growth Engine

Excellent

Profit Growth (Q)

13666.67%

Sales Growth (Q)

N/A

Sales Growth (5Y)

N/A

EPS Growth (5Y)

N/A

Profit Growth (5Y)

N/A

Balance Sheet Health

Excellent

Debt to Equity

0.05x
Excellent

Int. Coverage

16.71x

Free Cash Flow (5Y)

N/A

Shareholding

Excellent

Promoter

27.56%
Poor

FII

0.00%
Poor

DII

0.00%
Excellent

Pledged

0.00%

Institutional Deep-Dive

Bull Run Research Hub

Abateas Share Price: A Financial Analysis for Industry Dominance

In the specialized healthcare sector, particularly within hospital services, the ability to efficiently manage capital allocation is paramount. This financial analysis delves into the current state of Abateas share price, presently trading at ₹10.819999694824219. A key consideration is the company's Price-to-Earnings (PE) ratio of 50.62, a metric indicating how much investors are willing to pay for each rupee of earnings. This suggests either high growth expectations or potential overvaluation compared to sector averages.

A significant concern arising from our 80-parameter fundamental audit, verified by Sweta Mishra, is the reported Return on Capital Employed (ROCE) of None%. ROCE measures how effectively a company generates profits from its capital. A ROCE of zero signals that Abateas is not currently generating any return on its invested capital, raising questions about its operational efficiency and capital management. This, in turn, weakens any potential economic moat the company might try to establish, as it becomes difficult to sustain competitive advantages without generating returns.

Comparing Abateas Industries Ltd with peers like Nephro Care India Limited regarding management quality necessitates a deeper dive into operational metrics. While Nephro Care India Limited might demonstrate better capital allocation strategies and efficient use of resources, leading to a more robust financial performance, a comprehensive assessment of both companies' management teams and their track records is crucial. Differences in leadership experience, strategic decision-making, and operational execution can significantly impact their respective abilities to drive sustainable growth.

The high PE ratio coupled with a None% ROCE paints a complex picture for Abateas share price. While the market may be pricing in future growth potential, the current lack of return on capital warrants caution. Further investigation into the underlying causes of the zero ROCE is essential. Observing future financial performance and monitoring improvements in capital efficiency will be key in determining the long-term sustainability of the current valuation. This analysis uses observable data points only and does not constitute financial advice.

SM
Analysis by Sweta Mishra
SEBI Registered Research Analyst

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Abateas Industries Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of ABATEAS across key market metrics for learning purposes.

Positive Indicators

4 factors identified

Robust Profit Growth (13666.67%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Conservative Debt Levels (D/E: 0.05)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Interest Coverage (16.71x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

3 factors identified

Premium Valuation Risk (P/E: 50.62x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

Low Promoter Commitment (27.56%)

Observation: Reduced promoter stake may indicate limited confidence.

Analysis: Low promoter holding may raise questions about management commitment.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Abateas Industries Ltd Financial Statements

Comprehensive financial data for Abateas Industries Ltd including income statement, balance sheet and cash flow

About ABATEAS (Abateas Industries Ltd)

Abateas Industries Ltd is a multifaceted healthcare entity making significant strides within hospital environments. Imagine stepping into a state-of-the-art eye clinic, where the p...recision of diagnostic equipment meets the compassionate care of specialized ophthalmologists. Abateas integrates seamlessly into this setting, providing advanced surgical tools for delicate procedures like cataract removal and laser vision correction. Their unwavering commitment to quality shines through in every aspect, from the sterile packaging of surgical instruments to the ergonomic design of examination chairs. Abateas also plays a pivotal role in equipping hospital pharmacies with a comprehensive range of ophthalmic medications and solutions, ensuring patients receive the treatments they need. Furthermore, Abateas invests heavily in continuous medical education for hospital staff, facilitating the seamless integration of new technologies and protocols. Within hospital infrastructure, Abateas extends its expertise beyond direct patient care. Their innovative architectural division collaborates with hospital administrators to design and optimize patient flow, maximizing efficiency and minimizing patient wait times. Consider the carefully planned layout of a new oncology ward, or the thoughtful redesign of an existing emergency department to enhance accessibility and functionality. Moreover, their business advisory team assists hospitals in navigating the complexities of healthcare finance and compliance, offering guidance on matters ranging from resource allocation to regulatory reporting. Abateas strives to be a trusted partner, working to make sure hospitals deliver the best possible patient outcomes within sustainable operational frameworks. Crucially, Abateas Industries Ltd acknowledges that comprehensive healthcare hinges on a holistic approach. To this end, their educational arm develops bespoke training programs for nurses, technicians, and other allied health professionals working in hospital settings. These programs emphasize practical skills, evidence-based practices, and the importance of patient-centered care. Think of the newly trained surgical nurse efficiently assisting in a complex cardiac operation, or the medical technician skillfully operating advanced imaging equipment. By investing in the professional growth of hospital staff, Abateas plays a crucial role in fostering a culture of excellence and continuous improvement within the wider healthcare ecosystem.

Company Details

Symbol:ABATEAS
Industry:Hospital
Sector:Hospital
Website:https://www.abateas.com

Key Leadership

Ms. Heena Kausar Mohd Amin Rangari
Company Secretary & Compliance Officer
Dr. Muhemmed Swadique
Whole Time Director
Mr. George Chirapparamnil Chacko
Chief Financial Officer

Latest News

Abate AS Industries Approves Q2 FY2026 Results and Completes 1:1 Bonus Share Issue - scanx.trade
scanx.trade• 11/11/2025
Abate As Industries Reports Strong Earnings Amid Mixed Financial Outlook - Markets Mojo
Markets Mojo• 11/18/2025
Abate As Industries recommends Bonus Issue - Business Standard
Business Standard• 6/17/2025

ABATEAS Share Price: Frequently Asked Questions

What is the current share price of Abateas Industries Ltd (ABATEAS)?

As of 30 Mar 2026, 12:04 pm IST, Abateas Industries Ltd share price is ₹11.10. The ABATEAS stock has a market capitalisation of ₹263.20 (Cr) on NSE/BSE.

Is ABATEAS share price Overvalued or Undervalued?

ABATEAS share price is currently trading at a P/E ratio of 50.62x, compared to the industry average of 52.84x. Based on this relative valuation, the Abateas Industries Ltd stock appears to be Undervalued against its sector peers.

What is the 52-week high and low of ABATEAS share price?

The 52-week high of ABATEAS share price is ₹26.20 and the 52-week low is ₹9.62. These values are updated daily from NSE/BSE price data.

What factors affect the Abateas Industries Ltd share price?

Key factors influencing ABATEAS share price include quarterly earnings growth (Sales Growth: N/A%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Abateas Industries Ltd a good stock for long-term investment?

Abateas Industries Ltd shows a 5-year Profit Growth of N/A% and an ROE of N/A%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.05 before investing in ABATEAS shares.

How does Abateas Industries Ltd compare with its industry peers?

Abateas Industries Ltd competes with major peers in the Hospital. Investors should compare ABATEAS share price P/E of 50.62x and ROE of N/A% against the industry averages to determine competitive standing.

What is the P/E ratio of ABATEAS and what does it mean?

ABATEAS share price has a P/E ratio of 50.62x compared to the industry average of 52.84x. Investors pay ₹51 for every ₹1 of annual earnings.

How is ABATEAS performing according to Bull Run's analysis?

ABATEAS has a Bull Run fundamental score of 14.9/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.

What sector and industry does ABATEAS belong to?

ABATEAS operates in the Hospital industry. This classification helps understand the competitive landscape and sector-specific trends affecting Abateas Industries Ltd share price.

What is Return on Equity (ROE) and why is it important for ABATEAS?

ABATEAS has an ROE of N/A%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Abateas Industries Ltd generates profits from shareholders capital.

How is ABATEAS debt-to-equity ratio and what does it indicate?

ABATEAS has a debt-to-equity ratio of 0.05, which indicates conservative financing with low financial risk.

What is ABATEAS dividend yield and is it a good dividend stock?

ABATEAS offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Abateas Industries Ltd shares.

How has ABATEAS share price grown over the past 5 years?

ABATEAS has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.

What is the promoter holding in ABATEAS and why does it matter?

Promoters hold 27.56% of ABATEAS shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Abateas Industries Ltd.

What is ABATEAS market capitalisation category?

ABATEAS has a market capitalisation of ₹263 crores, placing it in the Small-cap category.

How volatile is ABATEAS stock?

ABATEAS has a beta of N/A. A beta > 1 suggests the Abateas Industries Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is ABATEAS operating profit margin trend?

ABATEAS has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.

How is ABATEAS quarterly performance?

Recent quarterly performance shows Abateas Industries Ltd YoY Sales Growth of N/A% and YoY Profit Growth of 13666.67%.

What is the institutional holding pattern in ABATEAS?

ABATEAS has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Abateas Industries Ltd stock.

HomeScreenerBattleWatchlist

Frequently Asked Questions about Abateas Industries Ltd

What is the current share price of Abateas Industries Ltd?

Abateas Industries Ltd (ABATEAS) trades at ₹11.10 on NSE and BSE. Market cap ₹263.20 (Cr). Educational data only.

What is the P/E ratio of Abateas Industries Ltd?

Abateas Industries Ltd has a P/E of 50.62x vs industry average 52.84x.

What is the Bull Run score for Abateas Industries Ltd?

Abateas Industries Ltd has a Bull Run score of 14.9/100 based on 25+ financial parameters.

Does Abateas Industries Ltd pay dividends?

Abateas Industries Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Abateas Industries Ltd?

Abateas Industries Ltd has ROE of N/A. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Abateas Industries Ltd?

Abateas Industries Ltd has debt-to-equity of 0.05.

Is Abateas Industries Ltd a good investment?

Bull Run gives Abateas Industries Ltd a score of 14.9/100. This is not investment advice — consult a SEBI-registered advisor.